Bednár tumor associated with dermal melanocytosis: Melanocytic colonization or neuroectodermal multidirectional differentiation?

Journal of Cutaneous Pathology

Volumn 30, Issue 2, 2003, Pages 147-151

  Goncharuk, Viktor ^a   Mulvaney, Michael ^b   Carlson, J Andrew ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b MC 81 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEDNAR TUMOR; CASE REPORT; CELL DIFFERENTIATION; CLINICAL FEATURE; DERMATOFIBROSARCOMA PROTUBERANS; DISEASE ASSOCIATION; FEMALE; HISTOGENESIS; HISTOPATHOLOGY; HUMAN; MELANOCYTOSIS; NEUROECTODERM; PUNCH BIOPSY;

ADULT; CELL DIFFERENTIATION; DERMATOFIBROSARCOMA; FEMALE; HUMANS; MELANOCYTES; NEURAL CREST; PIGMENTATION DISORDERS; SHOULDER; SKIN NEOPLASMS;

EID: 0037303930     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2003.00030.x     Document Type: Article

References (51)

1. Bednár B. Storiform neurofibromas of the skin, pigmented and nonpigmented. Cancer 1957; 10: 368.
2. Dupree WB, Langloss JM, Weiss SW. Pigmented dermatofibrosarcoma protuberans (Bednar tumor). A pathologic, ultrastructural, and immunohistochemical study. Am J Surg Pathol 1985; 9 (9): 630.
3. Gloster HM Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996, 35 (3 Part 1), 355; quiz 375-, 6.
4. Ratner D, Thomas CO et al. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol 1997; 37 (4): 600.
5. Marcus JR, Few JW, Senger C, Reynolds M. Dermatofibrosarcoma protuberans and the Bednar tumor: treatment in the pediatric population. J Pediatr Surg 1998; 33 (12): 1811.
6. Fletcher CD, Theaker JM, Flanagan A, Krausz T. Pigmented dermatofibrosarcoma protuberans (Bednar tumour): melanocytic colonization or neuroectodermal differentiation? A clinicopathological and immunohistochemical study. Histopathol 1988; 13 (6): 631.
7. Ozzello L, Hamels J. The histiocytic nature of dermatofibrosarcoma protuberans. Tissue culture and electron microscopic study. Am J Clin Pathol 1976; 65 (2): 136.
8. Escalona-Zapapta J, Alvarez-Fernandez E, Llorca-Escuin F. The fibroblastic nature of dermatofibrosarcoma protruberans. A tissue culture and ultrastructural study. Virchows Arch Path Anat Histol (A) 1981; 391: 165.
9. Alguacil-Garcia A, Unni K, Goellner J. Histogenesis of Dermatofibrosarcoma protruberans: An ultrastructural study. Am J Clin Pathol 1978; 69: 427.
10. Zina AM, Bundino S. Dermatofibrosarcoma protuberans. An ultrastructural study of five cases. J Cutan Pathol 1979; 6 (4): 265.
11. Fitzpatrick T, Lerner A, et al. Introduction to dermal pigment biology and dermal pigmentary disorders (ceruloderma), significance, physical basis, cytologic and biochemical basis. In: Fitzpatrick T, Kukita A, Morikawa F, Sober A, Toda K, eds. Biology and Diseases of Dermal Pigmentation. Tokyo: University of Tokyo Press, 1981; 21.
12. Barnhill RL. Dermal melanocytoses, blue nevi, and related conditions. In: Barnhill RL, ed. Pathology of Melanocytic Nevi and Malignant Melanoma. Boston: Butterworth-Heinemann, 1995; 131.
13. Hisanó A, Kasai K, Fukuzumi Y. An analysis of 114 patients with dermal melanocytosis on the trunk and extremities. Scand J Plast Reconstr Surg Hand Surg 1999; 33 (2): 231.
14. Stanford DG, Georgouras KE. Dermal melanocytosis: a clinical spectrum. Australas J Dermatol 1996; 37 (1): 19.
15. Hori Y, Kawashima M, Oohara K, Kukita A. Acquired, bilateral nevus of Ota-like macules. J Am Acad Dermatol 1984; 10 (6): 961.
16. Ono S, Hori M, Yamashita K, Yamakawa M. Generalised type of acquired dermal melanocytosis. Nippon Hifuka Gakkai Zasshi 1991; 101 (9): 965.
17. Mizushima J, Nogita T, Higaki Y, Horikoshi T, Kawashima M. Dormant melanocytes in the dermis: do dermal melanocytes of acquired dermal melanocytosis exist from birth? Br J Dermatol 1998; 139 (2): 349.
18. Levene A. On the natural history and comparative pathology of the blue naevus. Ann R Coll Surg Engl 1980; 62 (5): 327.
19. Sun J, Morton TH Jr, Gown AM. Antibody HMB-45 identifies the cells of blue nevi. An immunohistochemical study on paraffin sections. Am J Surg Pathol 1990; 14 (8): 748.
20. Machida H Jr PEM. The distribution of melanotic melanocytes in the skin of subhuman primates. In: Wand MFH, ed. The Pigmentary System. Advances in the Biology of the SkinVIII. Oxford: Pergamon Press, 1967; 41.
21. Reed RJ, Neuromesenchyme. The concept of a neurocristic effector cell for dermal mesenchyme. Am J Dermatopathol 1983; 5 (4): 385.
22. Gould V, Memoli V, Dardi L. Multidirectional differentiation in human epithelial cancers. J Submicrosc Cytol 1981; 13 (1): 97.
23. DeLellis RA, Tischler AS, Wolfe HJ. Multidirectional differentiation in neuroendocrine neoplasms. J Histochem Cytochem 1984; 32 (8): 899.
24. Carlson JA, Dickersin GR. Melanotic paraganglioid carcinoid tumor: a case report and review of the literature. Ultrastruct Pathol 1993; 17 (3): 353.
25. Azzopardi JG, Eusebi V. Melanocyte colonization and pigmentation of breast carcinoma. Histopathology 1977; 1 (1): 21.
26. Konomi K, Imayama S et al. Melanocyte chemotactic factor produced by skin metastases of a breast carcinoma. J Surg Oncol 1992; 50 (1): 62.
27. Carlson JA, Healy K, Slominski A, Mihm MC Jr. Melanocytic matricoma: a report of two cases of a new entity. Am J Dermatopathol 1999; 21 (4): 344.
28. Nakazawa K, Kalassy M, Sahuc F, Collombel C, Damour O. Pigmented human skin equivalent - as a model of the mechanisms of control of cell-cell and cell - matrix interactions. Med Biol Eng Comput 1998; 36 (6): 813.
29. Slominski A, Paus R et al. Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ. J Invest Dermatol 1996; 106 (6): 1203.
30. Carlson JA, Slominski A, Heasley D, Mihm MC Jr, Toda S. Dermatofibrosarcoma protuberans can induce epidermal hyperplasia that is inversely related to its proximity to the epidermis. Am J Dermatopathol 1998; 20 (4): 428.
31. Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol 1996; 20 (3): 277.
32. Nowell PC. The clonal evolution of tumor cell populations. Science 1976; 194 (4260): 23.
33. Karcioglu Z, Someren A, Mathes SJ. Ectomesenchymoma. A malignant tumor of migratory neural crest (ectomesenchyme) remnants showing ganglionic, schwannian, melanocytic and rhabdomyoblastic differentiation. Cancer 1977; 39 (6): 2486.
34. Smith KJ, Mezebish D, Williams J, Elgart ML, Skelton HG. The spectrum of neurocristic cutaneous hamartoma: clinicopathologic and immunohistochemical study of three cases. Ann Diagn Pathol 1998; 2 (4): 213.
35. Tremblay M, Bonenfant JL, Cliche J. Protuberant dermatofibrosarcoma. Clinicopathological study of 30 cases with ultrastructure of 2 cases. Union Med Can 1970; 99 (5): 871.
36. Hashimoto K, Brownstein MH, Jakobiec FA. Dermatofibrosarcoma protuberans. A tumor with perineural and endoneural cell features. Arch Dermatol 1974; 110 (6): 874.
37. Nakamura T, Ogata H, Katsuyama T. Pigmented dermatofibrosarcoma protuberans. Report of two cases as a variant of dermatofibrosarcoma protuberans with partial neural differentiation. Am J Dermatopathol 1987; 9 (1): 18.
38. Mochizuki Y, Narisawa Y, Kohda H. A case of Bednar tumor recurring after 23 years. J Dermatol 1996; 23 (9): 614.
39. Kiuru-Kuhlefelt S, El-Rifai W, et al. Concomitant DNA copy number amplification at 17q and 22q in dermatofibrosarcoma protuberans. Cytogenet Cell Genet 2001; 92 (3): 192.
40. Maire G, Martin L, Michalak-Provost S et al. Fusion of COL1A1 exon 29 with PDGFB exon 2 in a der(22)t(17;22) in a pediatric giant cell fibroblastoma with a pigmented Bednar tumor component. Evidence for age-related chromosomal pattern in dermatofibrosarcoma protuberans and related tumors. Cancer Genet Cytogenet 2002; 134 (2): 156.
41. Koga T, Iwasaki H, Ishiguro M, Matsuzaki A, Kikuchi M. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis. J Pathol 2002; 197 (1); 98.
42. Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 1993; 17 (10): 1039.
43. Cohen PR, Rapini RP, Farhood AI. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors. J Cutan Pathol 1993; 20 (1): 15.
44. Smith K, Germain M, Williams J, Skelton H. CD34-positive cellular blue nevi. J Cutan Pathol 2001; 28 (3): 145.
45. Hoang MP, Selim MA, Bentley RC, Burchette JL, Shea CR. CD34 expression in desmoplastic melanoma. J Cutan Pathol 2001; 28 (10): 508.
46. Abenoza P, Lillemoe T. CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans. Am J Dermatopathol 1993; 15 (5): 429.
47. Kutzner H. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol 1993; 28 (4): 613.
48. Nakamura H. Mesenchymal derivatives from the neural crest. Arch Histol Jpn 1982; 45 (2): 127.
49. Misago N, Narisawa Y, Inoue T, Yonemitsu N. Unusually differentiating immature nerve sheath myxoma in association with dermal melanocytosis. Am J Dermatopathol 1999; 21 (1): 55.
50. Misago N. The relationship between melanocytes and peripheral nerve sheath cells (Part I): melanocytic nevus (excluding so-called 'blue nevus') with peripheral nerve sheath differentiation. Am J Dermatopathol 2000; 22 (3): 217.
51. Misago N. The relationship between melanocytes and peripheral nerve sheath cells (Part II): blue nevus with peripheral nerve sheath differentiation. Am J Dermatopathol 2000; 22 (3): 230.